Type / Class
Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share
Shares outstanding
50,340,741
Total 13F shares
6,287,737
Share change
+276,483
Total reported value
$98,861,000
Price per share
$15.74
Number of holders
15
Value change
+$4,298,929
Number of buys
6
Number of sells
3

Security key

088786108

Report period

Q2 2020

Institutions

15

Top holders

10

Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
13F
Company
3.9%
1,957,961
$26,726,000 31 Mar 2020
13F
SV Health Investors, LLC
13F
Company
3.8%
1,915,274
$26,143,000 31 Mar 2020
13F
Atlas Venture Advisors, Inc.
13F
Company
2.7%
1,362,696
$18,601,000 31 Mar 2020
13F
Point72 Asset Management, L.P.
13F
Company
0.8%
400,499
$5,467,000 31 Mar 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.44%
219,734
$3,213,000 31 Mar 2020
13F
Laurion Capital Management LP
13F
Company
0.12%
57,892
$868,000 31 Mar 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.04%
18,800
$257,000 31 Mar 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.03%
15,241
$228,000 31 Mar 2020
13F
Squarepoint Ops LLC
13F
Company
0.03%
13,108
$179,000 31 Mar 2020
13F
Pentwater Capital Management LP
13F
Company
0.02%
12,500
$171,000 31 Mar 2020
13F
MORGAN STANLEY
13F
Company
0.01%
3,255
$44,000 31 Mar 2020
13F
Cubist Systematic Strategies, LLC
13F
Company
0%
294
$4,000 31 Mar 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
100
$1,000 31 Mar 2020
13F

Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC) as of Q2 2020

As of 30 Jun 2020, BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,287,737 shares. The largest 10 holders included TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Atlas Venture Advisors, Inc., Point72 Asset Management, L.P., FMR LLC, VICTORY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, Laurion Capital Management LP, ADVISOR GROUP HOLDINGS, INC., and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
12
Q2 2020 holders
15
Holder diff
3
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .